Ghelardini C, Galeotti N, Lelli C, Bartolini A. (2001). “Arecoline M1 receptor activation is a requirement for arecoline analgesia.”. Farmaco.56 (5–7): 383–5. doi:10.1016/S0014-827X(01)01091-6. PMID11482763.
Saikia JR, Schneeweiss FH, Sharan RN. (1999). “Arecoline-induced changes of poly-ADP-ribosylation of cellular proteins and its influence on chromatin organization.”. Cancer Letters.139 (1): 59–65. doi:10.1016/S0304-3835(99)00008-7. PMID10408909.
Christie JE, Shering A, Ferguson J (1981). “Physostigmine and arecoline: effects of intravenous infusions in Alzheimer’s presenile dementia”. British Journal of Psychiatry138: 46–50. doi:10.1192/bjp.138.1.46. PMID7023592.
nih.gov
pubmed.ncbi.nlm.nih.gov
Ghelardini C, Galeotti N, Lelli C, Bartolini A. (2001). “Arecoline M1 receptor activation is a requirement for arecoline analgesia.”. Farmaco.56 (5–7): 383–5. doi:10.1016/S0014-827X(01)01091-6. PMID11482763.
Yang YR, Chang KC, Chen CL, Chiu TH. (2000). “Arecoline excites rat locus coeruleus neurons by activating the M2-muscarinic receptor.”. Chin J Physiol.43 (1): 23–8. PMID10857465.
Xie DP, Chen LB, Liu CY, Zhang CL, Liu KJ, Wang PS. (2004). “Arecoline excites the colonic smooth muscle motility via M3 receptor in rabbits.”. Chin J Physiol.47 (2): 89–94. PMID15481791.
Saikia JR, Schneeweiss FH, Sharan RN. (1999). “Arecoline-induced changes of poly-ADP-ribosylation of cellular proteins and its influence on chromatin organization.”. Cancer Letters.139 (1): 59–65. doi:10.1016/S0304-3835(99)00008-7. PMID10408909.
Christie JE, Shering A, Ferguson J (1981). “Physostigmine and arecoline: effects of intravenous infusions in Alzheimer’s presenile dementia”. British Journal of Psychiatry138: 46–50. doi:10.1192/bjp.138.1.46. PMID7023592.
Yusuf H, Yong SL (2002). “Oral submucous fibrosis in a 12-year-old Bangladeshi boy: a case report and review of literature”. International journal of paediatric dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children12 (4): 271–6. PMID12121538.